Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Chronic hepatitis C is an important public health problem in Asia. We evaluated the safety, efficacy, and pharmacokinetics of fixed-dose ritonavir-boosted danoprevir plus pegin...
Saved in:
Main Authors: | Jia Horng Kao, Shui Yi Tung, Younjae Lee, Satawat Thongsawat, Tawesak Tanwandee, I. Shyan Sheen, Jinzi J. Wu, Hui Li, Barbara J. Brennan, Julian Zhou, Sophie Le Pogam, Isabel Najera, James A. Thommes, George Hill |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85002152541&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/56048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis
by: Kao J., et al.
Published: (2017) -
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
by: George K.K. Lau, et al.
Published: (2018) -
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
by: Lau G.K.K., et al.
Published: (2014) -
Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b
by: Sunida Kuakarn, et al.
Published: (2018) -
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
by: G. R. Foster, et al.
Published: (2018)